We are live on ! Find out more
LCS

Levin Capital Strategies Portfolio holdings

AUM $1.32B
1-Year Est. Return 28.11%
This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
+28.11%
3 Year Est. Return
+79.27%
5 Year Est. Return
+107.45%
10 Year Est. Return
+287.53%
AUM
$6.21B
AUM Growth
+$350M
Cap. Flow
-$172M
Cap. Flow %
-2.76%
Top 10 Hldgs %
35.82%
Holding
373
New
67
Increased
66
Reduced
99
Closed
54

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$99M
2
MCD icon
McDonald's
MCD
+$83M
3
PFE icon
Pfizer
PFE
+$81.5M
4
MDT icon
Medtronic
MDT
+$48.4M
5
FCX icon
Freeport-McMoran
FCX
+$47.3M

Sector Composition

Rank Sector Weight
1 Healthcare 15.54%
2 Financials 15.22%
3 Industrials 14.51%
4 Technology 13.7%
5 Energy 11.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GE icon
1
GE Aerospace
GE
$368B
$320M 5.15%
2,383,094
+114,120
+5% +$14.4M
ETN icon
2
Eaton
ETN
$142B
$299M 4.82%
3,930,725
-342,985
-8% -$24.4M
C icon
3
Citigroup
C
$215B
$266M 4.27%
5,095,932
+71,287
+1% +$3.61M
PFE icon
4
Pfizer
PFE
$143B
$250M 4.02%
8,597,339
-2,800,526
-25% -$81.5M
MRK icon
5
Merck
MRK
$322B
$249M 4.01%
5,214,759
+1,646,818
+46% +$75.3M
OXY icon
6
Occidental Petroleum
OXY
$55.5B
$190M 3.07%
2,090,787
-134,979
-6% -$12.3M
CAM
7
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
$174M 2.8%
+2,926,252
New +$169M
AAPL icon
8
Apple
AAPL
$5.03T
$166M 2.68%
8,308,972
-2,378,656
-22% -$44.9M
ORCL icon
9
Oracle
ORCL
$346B
$160M 2.57%
4,178,688
-739,126
-15% -$25.4M
PF
10
DELISTED
Pinnacle Foods, Inc.
PF
$151M 2.43%
5,498,521
+1,790,432
+48% +$48.6M
HOLX
11
DELISTED
Hologic
HOLX
$137M 2.2%
6,127,722
+1,555,428
+34% +$34.3M
TAP icon
12
Molson Coors Class B
TAP
$7.96B
$136M 2.19%
2,424,537
-363,903
-13% -$19.5M
PCG icon
13
PG&E
PCG
$39B
$133M 2.14%
3,298,962
+108,422
+3% +$4.44M
RDS.A
14
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$132M 2.12%
1,851,030
-192,608
-9% -$12.9M
WFC icon
15
Wells Fargo
WFC
$255B
$125M 2.01%
2,749,741
-126,030
-4% -$5.44M
QCOM icon
16
Qualcomm
QCOM
$171B
$123M 1.98%
1,653,113
-569,909
-26% -$40.2M
WPX
17
DELISTED
WPX Energy, Inc.
WPX
$119M 1.92%
5,846,463
+2,010,604
+52% +$40.1M
CIT
18
DELISTED
CIT Group Inc.
CIT
$117M 1.88%
2,239,246
-493,754
-18% -$24.5M
EMC
19
DELISTED
EMC CORPORATION
EMC
$114M 1.84%
4,535,864
+986,303
+28% +$23.9M
JPM icon
20
JPMorgan Chase
JPM
$922B
$114M 1.83%
1,942,697
-61,794
-3% -$3.39M
CAG icon
21
Conagra Brands
CAG
$7.41B
$102M 1.65%
3,900,200
-473,697
-11% -$11.8M
BIO icon
22
Bio-Rad Laboratories Class A
BIO
$8.81B
$99.2M 1.6%
802,906
-61,328
-7% -$7.47M
DD
23
DELISTED
Du Pont De Nemours E I
DD
$93.3M 1.5%
1,511,665
-427,798
-22% -$24.7M
MET icon
24
MetLife
MET
$62.5B
$81.6M 1.31%
1,698,434
-152,497
-8% -$6.84M
ALL icon
25
Allstate
ALL
$70.2B
$73.7M 1.19%
+1,351,598
New +$72.1M

Similar funds

Levin Capital Strategies's Q4 2013 Portfolio in Review

As of Q4 2013, Levin Capital Strategies held 373 positions worth $6.21B, up 6% from $5.86B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Levin Capital Strategies's Q4 2013 filing shows 67 new, 66 increased, 99 reduced and 54 closed positions. Its largest new stake was CAMERON INTERNATIONAL CORPORATION: 2,926,252 shares worth $174M. The largest sale was Verizon, an estimated $99M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Financials and Industrials.

  • Levin Capital Strategies's largest Q4 2013 buy was CAMERON INTERNATIONAL CORPORATION: 2,926,252 shares worth $174M.
  • Levin Capital Strategies added most to Merck in Q4 2013, an estimated $75.3M increase.
  • Levin Capital Strategies's biggest Q4 2013 reduction was Verizon, cutting an estimated $99M.
  • Levin Capital Strategies fully exited McDonald's in Q4 2013, selling an estimated $83M.
  • Levin Capital Strategies's ten largest holdings make up 36% of its $6.21B portfolio in Q4 2013.
  • Levin Capital Strategies opened 67 new positions and closed 54 in Q4 2013.
  • Levin Capital Strategies's portfolio value rose 6% quarter-over-quarter to $6.21B.

Based on Levin Capital Strategies's 13F filing for Q4 2013, filed 13 Feb 2014.